Frontlight ResearchEarly access
Chronic kidney disease trials in France
56 of 85 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleBelatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction
- Where
- Nantes
- Age
- 18 years to 99 years
- People
- 30
- Run by
- Nantes University Hospital
See details and how to joinNCT05562869 - No phaseNot yet taking people in FranceTOMO-QALY: Peer Mentoring in Chronic Kidney Disease
- Where
- Avranches, Caen, Cherbourg, Flers, Saint-Lô
- Age
- 18 years and over
- People
- 260
- Run by
- University Hospital, Caen
See details and how to joinNCT07931911 - Phase 2Taking peopleImlifidase Prior to Kidney Transplant in Highly Sensitised Children
- Where
- Paris
- Age
- 1 year to 17 years
- People
- 10 worldwide
- Run by
- Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00 - Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Amiens Cedex 1, Bois-Guillaume, Bordeaux, Boulogne-Billancourt, Brest, Clermont Ferrand Cedex 1, Creteil, La Roche Sur Yon Cedex 9, Le Mans Cedex 9, Limoges, Lyon Cedex 03, Marseille, Nancy Cedex, Nantes, Nice, Nimes Cedex 9, Paris, Paris Cedex 18, Pierre-Bénite, Poitiers, Quimper Cedex, Reims, Saint-Priest-en-Jarez, Sarcelles, Strasbourg Cedex, Tours
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - No phaseTaking peopleInvestigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
- Where
- Paris
- Age
- 18 years and over
- People
- 165
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07604922 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Bois-Guillaume, Clermont-Ferrand, La Tronche, Le Coudray, Lyon, Mulhouse, Nantes, Nice, Paris, Saint-Herblain, Toulouse Cedex 9, Tours Cedex 9, Vandoeuvre Les Nancy
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseTaking peopleEvaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis Patients
- Where
- Annecy, Chambéry
- Age
- 18 years and over
- People
- 450
- Run by
- Centre Hospitalier Annecy Genevois
See details and how to joinNCT07651436 - No phaseNot yet taking people in FranceEvaluation of the Effect of Light Therapy on the Evolution of Self-reported Depressive Disorders in Chronic Hemodialysis Patients
- Where
- Annecy
- Age
- 18 years and over
- People
- 340
- Run by
- Centre Hospitalier Annecy Genevois
See details and how to joinNCT07729358 - No phaseNot yet taking people in FranceA Minute for my Kidneys
- Where
- Lille
- Age
- 18 years to 80 years
- People
- 312
- Run by
- GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07869849 - Phase 3Taking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Marseille, Montpellier Cedex 5, Paris
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - Phase 1/2Taking peopleStudy of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Where
- Villejuif
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- Oncorena AB
See details and how to joinNCT05287945 - Phase 3Active, not recruitingA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Bordeaux, Bron, Montpellier, Paris, Strasbourg Cedex 2, Toulouse Cedex 9
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 3Not yet taking people in FranceA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Boulogne-sur-Mer, Caen, Cherbourg, Colmar, La Roche-sur-Yon, Le Mans, Marseille, Nîmes, Orléans, Rouen, Saint-Priez En Jarez, Toulouse, Tours
- Age
- 18 years to 99 years
- People
- 2,800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Amiens, Aura, Brest, Caen, Compiègne, Grabels, Lille, Limoges, Marseille, Montpellier, Nice, Nîmes, Paris, Reims, Saint-Ouen, Strasbourg, Toulouse
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleProspective Analysis of Self Medication With Phytotherapy in Nephropatic Patients.
- Where
- Saint-Benoît, Saint-Denis, Saint-Paul, Saint-Pierre
- Age
- 18 years and over
- People
- 400
- Run by
- Centre Hospitalier Universitaire de la Réunion
See details and how to joinNCT07444515 - Phase 4Taking peopleEffect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
- Where
- Nice
- Age
- 18 years to 80 years
- People
- 34
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07074418 - No phaseNot yet taking people in FranceCXCR2 Leucocyte Expression Level as a Predictive Factor of Coronary Artery Calcification Progression in Advanced Chronic Kidney Disease Patients
- Where
- Amiens
- Age
- 18 years and over
- People
- 100
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07811505 - Phase 3Taking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Bordeaux, Clermont-Ferrand, Corbeil-Essonnes, Epagny Metz-tessy, Grenoble Cedex 9, La Rochelle, Laval, Le Kremlin-Bicetre, Le Puy-En-Velay, Lyon, Montpellier, Nantes, Orleans Cedex 2, Pierre-Bénite, Pontoise, Saint-Priest-en-Jarez, Toulouse Cedex 9, Valenciennes
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - No phaseTaking peoplePragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
- Where
- Paris
- Age
- 18 years and over
- People
- 3,600 worldwide
- Run by
- The University of Queensland
See details and how to joinNCT03573089 - Phase 3TerminatedA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
- Where
- Bron, Paris
- Age
- 2 years to 17 years
- People
- 24 worldwide
- Run by
- Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00 - No phaseTaking peopleImpact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis
- Where
- Le Puy-en-Velay, Lyon, Moulins, Poissy
- Age
- 18 years to 85 years
- People
- 240
- Run by
- Centre Hospitalier Emile Roux
See details and how to joinNCT06708338 - No phaseNot yet taking people in FranceAssessment of Dietary Balance in Home-Dwelling Patients With Stage 4 and 5 Chronic Kidney Disease Using URIKI (IKI), a Connected Urine Test Strip and In Vitro Diagnostic Medical Device
- Where
- Paris
- Age
- 18 years and over
- People
- 450
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07746037 - Phase 3Taking peopleIntensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
- Where
- Angers Cedex 9, Bordeaux, Brest Cedex 2, Chalon Sur Saone Cedex, Clermont-Ferrand, Colmar Cedex, Grenoble Cedex 9, Haguenau, La Roche Sur Yon Cedex 9, Le Coudray, Le Mans, Le Puy-En-Velay, Lille, Limoges, Lyon Cedex 03, Marseille, Metz Cedex 03, Mulhouse, Nantes, Nimes Cedex 9, Orleans Cedex 2, Paris, Paris Cedex 18, Perpignan Cedex, Reims, Rennes Cedex 9, Reze, Roubaix, Rouen Cedex, Saint-Gregoire, Saint-Herblain, Saint-Malo Cedex, Saint-Priest-en-Jarez, Strasbourg, Tours, Valenciennes, Vandoeuvre Les Nancy
- Age
- 18 years and over
- People
- 720
- Run by
- University Hospital, Tours
See details and how to joinNCT05732727 · EU 2022-501494-39-00 - No phaseNot yet taking people in FranceAssociation Between Chronic Kidney Disease Stage and Circulating FGF23 Cleavage Intensity in Patients With Chronic Kidney Disease
- Where
- Saint-Etienne
- Age
- 55 years to 75 years
- People
- 80
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT07676526 - No phaseTaking peopleInorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease
- Where
- Nice
- Age
- 0 years to 18 years
- People
- 60
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT06300788